ArticleMedical gas research2027
Rectal ozone insufflation modulates gut microbiota: improving lung function in mice with chronic obstructive pulmonary disease.
Article in Medical gas research, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ozone rectal insufflation possesses anti-inflammatory and antioxidant effects and is used for the treatment and prevention of diseases. This study aimed to investigate the effects of ozone rectal insufflation on chronic obstructive pulmonary disease and explore the potential underlying mechanisms from the perspective of gut microbiology. A mouse chronic obstructive pulmonary disease model was established by intratracheal spraying of lipopolysaccharide and elastase. Mice received ozone rectal insufflation intervention following modeling. We found that ozone rectal insufflation improved pulmonary function, alleviated emphysema and pulmonary fibrosis, and reduced inflammatory cytokine levels in the bronchoalveolar lavage fluid of chronic obstructive pulmonary disease mice. Additionally, ozone rectal insufflation modulated the pathogenic-to-beneficial gut bacteria ratio in chronic obstructive pulmonary disease mice. The treatment also led to an upregulation of short-chain fatty acids. The fecal microbiota transplantation results further confirmed that the gut microbiota of ozone rectal insufflation-treated mice was sufficient to attenuate chronic obstructive pulmonary disease symptoms. In summary, our findings indicate that ozone rectal insufflation enhances lung function and reduces inflammation in chronic obstructive pulmonary disease mice by modulating the gut microbiota and its associated metabolites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.